The ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies.

CNTY-101 - Century Therap

https://meetings.asco.org/abstracts-presentations/226004

Krish Patel; Sarah Rothman; Poulomee A Das; Stephanie Yee; Indu Ramachandran; Iphigenia Koumenis; Terry A Cook; Ying Yuan; Nikolaus S. Trede; Ahmad Hatem Mattour

Apr 27, 2023